Ethical issues abound in adoption of AI in cancer care

by Lori SolomonThere may be ethical barriers to the adoption of artificial intelligence (AI) into cancer care, according to a studypublishedonline March 28 inJAMA Network Open.Andrew

Updated on: April 06,2024 0

Ethical issues abound in adoption of AI in cancer care

by Lori SolomonThere may be ethical barriers to the adoption of artificial intelligence (AI) into cancer care, according to a studypublishedonline March 28 inJAMA Network Open.Andrew

Updated on:April 06,2024 0

Using cryo-shocked tumor cells to fight lung cancer

by Bob Yirka , Medical XpressSchedule of LNT cells delivery of CRISPR-Cas9 nanoparticles for KRAS-mutant NSCLC treatment. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adk8264A team o

Updated on: April 06,2024 0

Using cryo-shocked tumor cells to fight lung cancer

by Bob Yirka , Medical XpressSchedule of LNT cells delivery of CRISPR-Cas9 nanoparticles for KRAS-mutant NSCLC treatment. Credit:Science Advances(2024). DOI: 10.1126/sciadv.adk8264A team o

Updated on:April 06,2024 0

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on: April 06,2024 0

Bladder cancer treatment can be better targeted and more effective, trials show

by European Association of UrologyCredit: Unsplash/CC0 Public DomainTesting for tumor DNA in the blood can successfully identify advanced bladder cancer patients who will not relapse following su

Updated on:April 06,2024 0

Microbial signature of colorectal cancer-associated mutations identified

by American Society for MicrobiologyCredit: CC0 Public DomainFor about 40% of people diagnosed with colorectal cancer (CRC), the tumor carries a mutation in a gene called KRAS. Many of those muta

Updated on: April 06,2024 0

Microbial signature of colorectal cancer-associated mutations identified

by American Society for MicrobiologyCredit: CC0 Public DomainFor about 40% of people diagnosed with colorectal cancer (CRC), the tumor carries a mutation in a gene called KRAS. Many of those muta

Updated on:April 06,2024 0

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test

Updated on: April 06,2024 0

Five-year interval is safe for prostate cancer screening, research shows

by European Association of UrologyCredit: CC0 Public DomainA simple blood test every five years is sufficient to screen low risk men for prostate cancer, new research has shown.The PSA blood test

Updated on:April 06,2024 0

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy

by Kindai UniversityThe concentration of soluble PD-L1m PD-1, CTLA4 in plasma were highly correlated with the expression of genes associated with exhaustion in the peripheral CD8+T cells. R valu

Updated on: April 06,2024 0

Soluble immune checkpoint factors in blood as potential biomarkers of therapeutic efficacy for ICI cancer immunotherapy

by Kindai UniversityThe concentration of soluble PD-L1m PD-1, CTLA4 in plasma were highly correlated with the expression of genes associated with exhaustion in the peripheral CD8+T cells. R valu

Updated on:April 06,2024 0

Fighting pancreatic cancer with computers and lasers

by Anthony King,Horizon: The EU Research & Innovation MagazinePancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteFaster detection

Updated on: April 06,2024 0

Fighting pancreatic cancer with computers and lasers

by Anthony King,Horizon: The EU Research & Innovation MagazinePancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteFaster detection

Updated on:April 06,2024 0

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on: April 06,2024 0

A new hope in immunotherapy against cancer

by Karolinska InstitutetIdentification of SB02024 as a potent and selective inhibitor of VPS34. (A) Chemical structure of SB02024. (B) Cartoon representation of the structure of complex between V

Updated on:April 06,2024 0

New insights into how tumors on adrenal glands develop

by Kyushu UniversitySteroids-producing nodules, or SPNs, exhibit a two-layered zona fasciculata (zF) and zona reticularis (zR) like structure, where two distinct cell populations might contribute

Updated on: April 06,2024 0

New insights into how tumors on adrenal glands develop

by Kyushu UniversitySteroids-producing nodules, or SPNs, exhibit a two-layered zona fasciculata (zF) and zona reticularis (zR) like structure, where two distinct cell populations might contribute

Updated on:April 06,2024 0

New study targets major risk factor for gastric cancer

by University of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainWhat if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable

Updated on: April 06,2024 0

New study targets major risk factor for gastric cancer

by University of Miami Leonard M. Miller School of MedicineCredit: CC0 Public DomainWhat if we could eliminate a major risk factor for stomach cancer in Black, Asian, Latino and other vulnerable

Updated on:April 06,2024 0

New insights into aggressive breast cancer and potential treatment options

by Marianne Lie Becker,University of Southern DenmarkThe findings made in the recent research projects. Credit: Professor Vijay Tiwari, University of Southern DenmarkTriple-negative breast cance

Updated on: April 06,2024 0

New insights into aggressive breast cancer and potential treatment options

by Marianne Lie Becker,University of Southern DenmarkThe findings made in the recent research projects. Credit: Professor Vijay Tiwari, University of Southern DenmarkTriple-negative breast cance

Updated on:April 06,2024 0

Study shows 'feasibility' of ending specialist follow-up in patients with low-risk chronic lymphocytic leukemia

by American Society of HematologyCredit: CC0 Public DomainA study published inBlood Advancesshowed that among patients in Denmark who had slow-growing chronic lymphocytic leukemia (CL

Updated on: April 06,2024 0

Study shows 'feasibility' of ending specialist follow-up in patients with low-risk chronic lymphocytic leukemia

by American Society of HematologyCredit: CC0 Public DomainA study published inBlood Advancesshowed that among patients in Denmark who had slow-growing chronic lymphocytic leukemia (CL

Updated on:April 06,2024 0